BioLargo Presentation Deck at LD Micro Event Available Online
BioLargo (OTCQX: BLGO) announced that its CEO presented at the LD Micro Main Event XIX on October 20, 2025 at the Hotel del Coronado in San Diego.
The presentation covered Cellinity battery cell technology, BioLargo’s role in the global AI infrastructure investment cycle, and a general corporate update. The company filed a Form 8-K on October 20, 2025 to provide the presentation materials, which are available online at the company’s SEC filings page: https://www.biolargo.com/sec-filings.
BioLargo (OTCQX: BLGO) ha annunciato che il suo CEO ha presentato al LD Micro Main Event XIX il 20 ottobre 2025 all'Hotel del Coronado a San Diego.
La presentazione ha riguardato Cellinity battery cell technology, il ruolo di BioLargo nel global AI infrastructure investment cycle e un aggiornamento generale sulla società. L'azienda ha presentato un Form 8-K il 20 ottobre 2025 per fornire i materiali della presentazione, disponibili online sulla pagina delle filing SEC dell'azienda: https://www.biolargo.com/sec-filings.
BioLargo (OTCQX: BLGO) anunció que su CEO presentó en el LD Micro Main Event XIX el 20 de octubre de 2025 en el Hotel del Coronado en San Diego.
La presentación cubrió Cellinity battery cell technology, el papel de BioLargo en el global AI infrastructure investment cycle y una actualización corporativa general. La compañía presentó un Form 8-K en 20 de octubre de 2025 para proporcionar los materiales de la presentación, que están disponibles en línea en la página de presentaciones de la SEC de la compañía: https://www.biolargo.com/sec-filings.
BioLargo (OTCQX: BLGO)는 CEO가 LD Micro Main Event XIX에서 2025년 10월 20일 샌디에이고의 호텔 델 코로도에서 발표했다고 발표했습니다.
발표 내용은 Cellinity battery cell technology, 글로벌 AI 인프라 투자 사이클에서 BioLargo의 역할, 그리고 일반적인 기업 업데이트를 다뤘습니다. 회사는 발표 자료를 제공하기 위해 2025년 10월 20일에 Form 8-K를 제출했으며, 이는 회사의 SEC 제출 페이지에서 온라인으로 확인할 수 있습니다: https://www.biolargo.com/sec-filings.
BioLargo (OTCQX: BLGO) a annoncé que son PDG a pris la parole lors du LD Micro Main Event XIX le 20 octobre 2025 à l'hôtel del Coronado à San Diego.
La présentation a porté sur Cellinity battery cell technology, le rôle de BioLargo dans le global AI infrastructure investment cycle et une mise à jour générale de l'entreprise. La société a déposé un Form 8-K le 20 octobre 2025 pour fournir les supports de présentation, disponibles en ligne sur la page des dépôts SEC de la société : https://www.biolargo.com/sec-filings.
BioLargo (OTCQX: BLGO) gab bekannt, dass sein CEO am LD Micro Main Event XIX am 20. Oktober 2025 im Hotel del Coronado in San Diego präsentiert hat.
Die Präsentation behandelte Cellinity battery cell technology, BioLargos Rolle im global AI infrastructure investment cycle und ein allgemeines Unternehmensupdate. Das Unternehmen hat am 20. Oktober 2025 ein Form 8-K eingereicht, um die Präsentationsunterlagen zur Verfügung zu stellen, die online auf der SEC-Filings-Seite des Unternehmens zu finden sind: https://www.biolargo.com/sec-filings.
BioLargo (OTCQX: BLGO) أعلنت أن مديرها التنفيذي قدم في LD Micro Main Event XIX في 20 أكتوبر 2025 في فندق ديل كورونادو في سان دييغو.
تناولت العرض Cellinity battery cell technology، ودور BioLargo في دورة استثمار بنية AI التحتية العالمية وتحديثاً عاماً للشركة. قدمت الشركة FORM 8-K في 20 أكتوبر 2025 لتوفير مواد العرض، والمتاحة على صفحة ملفات SEC الخاصة بالشركة على الإنترنت: https://www.biolargo.com/sec-filings.
BioLargo (OTCQX: BLGO) 宣布其首席执行官在 LD Micro Main Event XIX 的 2025 年 10 月 20 日 于圣地亚哥的 Coronado 酒店进行了演讲。
演讲内容包括 Cellinity battery cell technology、BioLargo 在 全球 AI 基础设施投资周期中的角色，以及公司的一般更新。公司已于 2025 年 10 月 20 日 提交了 Form 8-K 以提供演示材料，材料可在公司的 SEC 报告页面在线查看：https://www.biolargo.com/sec-filings。
- None.
- None.
Cellinity battery cell technology, BioLargo's role in the global AI infrastructure investment cycle, and a general corporate update are featured in the presentation.
WESTMINSTER, CA, CA / ACCESS Newswire / October 21, 2025 / BioLargo, Inc. (OTCQX:BLGO), a cleantech innovator that creates and commercializes sustainable technologies, today announced that its CEO presented at the LD Micro Main Event XIX, held at the Hotel del Coronado in San Diego, California, on Monday, October 20, at 2:00 p.m. Pacific Time.
In connection with the event, the company filed a Form 8-K on October 20, 2025, to provide a copy of the presentation materials, which are now available online and can be viewed at the following link: https://www.biolargo.com/sec-filings
About BioLargo, Inc.
BioLargo, Inc. (OTCQX:BLGO) is a cleantech and life sciences innovator and engineering services solution provider. Its core products address PFAS contamination, achieve advanced water and wastewater treatment, control odor and VOCs, improve air quality, enable energy efficiency and safe on-site energy storage, and control infections and infectious disease. BioLargo's approach is to invent or acquire novel technologies, develop them into commercial offerings, and extend their reach through licensing and channel partnerships to maximize their impact. Visit www.BioLargo.com.
Contact Information
Dennis P. Calvert
President and CEO, BioLargo, Inc.
888-400-2863
Safe Harbor Act
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, without limitation, those regarding BioLargo's ("the Company") expectations about anticipated revenue and plans for future operations. These statements involve risks and uncertainties, and actual results may differ materially from those expressed or implied. More information on these risks and other potential factors is included in the Company's filings with the SEC, including its most recent Form 10-K, Form 10-Q, and subsequent filings. The Company assumes no obligation to update any forward-looking statements or information, which speak as of their respective dates.
SOURCE: BioLargo, Inc
View the original press release on ACCESS Newswire
FAQ
What did BioLargo (BLGO) present at LD Micro Main Event XIX on October 20, 2025?
When and where did BioLargo (BLGO) present at the LD Micro event?
Where can investors view BioLargo's (BLGO) LD Micro presentation materials?
Does the LD Micro presentation include financial guidance or earnings for BioLargo (BLGO)?
How does BioLargo (BLGO) describe its involvement in AI infrastructure in the presentation?
Was BioLargo's (BLGO) LD Micro presentation formally filed with the SEC?
